Marge Harris Xanelim Patient

Diagnosed with psoriasis as an infant, Marge Harris has been plagued with flare-ups and skin lesions over much of her body surface throughout her life. She's tried virtually every treatment available, with little or no relief. Today, Marge is participating in a clinical trial of the therapeutic antibody Xanelim, which is being developed by Genentech and Xoma Ltd. Her flare-ups are down to a minimum, and she's never felt or looked better.

During the quarter, Genentech announced initial positive results from a Phase III investigational trial of Xanelim for adults with moderate-to-severe plaque psoriasis. Learn more about this and Genentech's other second quarter milestones in this report.